As consumers, we’re forced to check our labels carefully, and if we have the recalled item in our possession, we either return it for a refund or discard it completely. But not every food safety issue ...

The recall came after the Canadian Food Inspection Agency revealed the presence of Listeria monocytogene in the fresh sliced ...

Ice cream makers representing about 90% of the U.S. supply of the frozen treat have pledged to remove artificial dyes from their products in less than three years, federal health officials said Monday ...

However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...

"EQUIP-A-Pharma is about point-of-need manufacturing—hospitals, military bases, disaster zones—ensuring rapid drug ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

President Trump has threatened to slap a 200% tariff on foreign-made pharmaceuticals. That would roil the $200 billion-plus ...

Looming threats to the pharmaceutical supply chain have brought fresh attention to onshoring. Experts say innovation is ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...